LIFERIVER(SH:688317) Sou Hu Cai Jing·2025-07-30 10:21Group 1 - The core viewpoint of the article highlights the recent performance and financial metrics of Zhijiang Biological (688317), indicating a decline in stock price and significant decreases in revenue and profit [1] - As of July 30, 2025, Zhijiang Biological's stock closed at 23.73 yuan, down 1.94%, with a trading volume of 82,800 hands and a transaction amount of 200 million yuan [1] - The company experienced a net outflow of main funds amounting to 10.56 million yuan, representing 5.27% of the transaction amount, with large orders contributing to the outflow [1] Group 2 - For the first quarter of 2025, Zhijiang Biological reported total operating revenue of 32.13 million yuan, a year-on-year decrease of 37.27%, and a net profit attributable to shareholders of 16.02 million yuan, down 159.53% [1] - The company has a current ratio of 21.41, a quick ratio of 21.04, and a debt-to-asset ratio of 6.41% [1] - Zhijiang Biological, established in 2005 and located in Shanghai, has a registered capital of approximately 1.92 billion yuan and a paid-in capital of about 740 million yuan [1] Group 3 - Zhijiang Biological has made investments in 9 companies and participated in 759 bidding projects, indicating active engagement in business development [2] - The company holds 57 trademark registrations and 55 patents, showcasing its focus on intellectual property [2] - Additionally, Zhijiang Biological possesses 225 administrative licenses, reflecting its compliance and operational capabilities [2]